Association between the intake of α-linolenic acid and the risk of CHD

Mia Sadowa Vedtofte, Marianne Uhre Jakobsen, Lotte Lauritzen, Eilis J. O'Reilly, Jarmo Virtamo, Paul Knekt, Graham Colditz, Goran Hallmans, Julie Buring, Lyn M. Steffen, Kimberly Robien, Eric B. Rimm, Berit L. Heitmann

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

The intake of the mainly plant-derived n-3 PUFA alpha-linolenic acid (ALA) has been reported to be associated with a lower risk of CHD. However, the results have been inconsistent. Therefore, the objective of the present study was to examine the association between the intake of ALA and the risk of CHD. Potential effect modification by the intake of long-chain n-3 PUFA (n-3 LCPUFA) was also investigated. Data from eight American and European prospective cohort studies including 148 675 women and 80 368 men were used. The outcome measure was incident CHD (CHD event and death). During 4-10 years of follow-up, 4493 CHD events and 1751 CHD deaths occurred. Among men, an inverse association (not significant) between the intake of ALA and the risk of CHD events and deaths was observed. For each additional gram of ALA consumed, a 15% lower risk of CHD events (hazard ratios (HR) 0.85, 95% CI 0.72, 1.01) and a 23% lower risk of CHD deaths (HR 0.77, 95% CI 0.58, 1.01) were observed. No consistent association was observed among women. No effect modification by the intake of n-3 LCPUFA was observed.
Original languageEnglish
JournalBritish Journal of Nutrition
Volume112
Issue number5
Pages (from-to)735-743
Number of pages9
ISSN0007-1145
DOIs
Publication statusPublished - 2014
Externally publishedYes

Keywords

  • α-Linolenic acid
  • CHD
  • Epidemiology

Fingerprint Dive into the research topics of 'Association between the intake of α-linolenic acid and the risk of CHD'. Together they form a unique fingerprint.

Cite this